Guinea pig ascorbate status predicts tetrahydrobiopterin plasma concentration and oxidation ratio in vivo

Nutrition Research

Volumn 33, Issue 10, 2013, Pages 859-867

  Mortensen, Alan ^a   Hasselholt, Stine ^a   Tveden Nyborg, Pernille ^a   Lykkesfeldt, Jens ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Ascorbic acid; Dihydrobiopterin; Guinea pig; In vivo oxidation; Tetrahydrobiopterin

Indexed keywords

ASCORBIC ACID; DEHYDROASCORBIC ACID; DIHYDROBIOPTERIN; TETRAHYDROBIOPTERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIETARY INTAKE; GUINEA PIG; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ANIMALIA; CAVIA;

ASCORBIC ACID; BH(2); BH(4); DEHYDROASCORBIC ACID; DHA; DIHYDROBIOPTERIN; DITHIOERYTHRITOL; DTE; ED; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENOS; GUINEA PIG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HPLC; IN VIVO OXIDATION; META-PHOSPHORIC ACID; MPA; NITRIC OXIDE SYNTHASE; NOS; TETRAHYDROBIOPTERIN;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; ASCORBIC ACID DEFICIENCY; BIOPTERIN; DEHYDROASCORBIC ACID; ENDOTHELIUM, VASCULAR; GUINEA PIGS; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 84884592807     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2013.07.006     Document Type: Article

References (92)

1. Frikke-Schmidt H., Lykkesfeldt J. Role of marginal vitamin C deficiency in atherogenesis: in vivo models and clinical studies. Basic Clin Pharmacol Toxicol 2009, 104:419-433.
2. Katusic Z.S. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?. Am J Physiol 2001, 281:H981-H986.
3. Werner E.R., Blau N., Thöny B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J 2011, 438:397-414.
4. Vásquez-Vivar J., Martásek P., Whitsett J., Joseph J., Kalyanaraman B. The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochem J 2002, 362:733-739.
5. Crabtree M.J., Smith C.L., Lam G., Goligorsky M.S., Gross S.S. Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS. Am J Physiol 2008, 294:H1530-H1540.
6. 2): key determinant in influencing arginine mediated endothelial tolerance and dysfunction. Am J Biochem Biotech 2012, 8:54-62.
7. Kuzkaya N., Weissmann N., Harrison D.G., Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols. J Biol Chem 2003, 278:22546-22554.
8. Takeda M., Yamashita T., Shinohara M., Sasaki N., Takaya T., Nakajima K., et al. Plasma tetrahydrobiopterin/dihydrobiopterin ratio: a possible marker of endothelial dysfunction. Circ J 2009, 73:955-962.
9. Noguchi K., Hamadate N., Matsuzaki T., Sakanashi M., Nakasone J., Uchida T., et al. Increasing dihydrobiopterin causes dysfunction of endothelial nitric oxide synthase in rats in vivo. Am J Physiol 2011, 301:H721-H729.
10. Kar S., Kavdia M. Modeling of biopterin-dependent pathways of eNOS for nitric oxide and superoxide production. Free Radic Biol Med 2011, 51:1411-1427.
11. Crabtree M.J., Tatham A.L., Al-Wakeel Y., Warrick N., Hale A.B., Cai S., et al. Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status. J Biol Chem 2009, 284:1136-1144.
12. Lykkesfeldt J., Poulsen H.E. Is vitamin C supplementation beneficial? Lessons learned from randomised controlled trials. Br J Nutr 2010, 103:1251-1259.
13. Huang A., Vita J.A., Venema R.C., Keaney J.F. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 2000, 275:17399-17406.
14. Heller R., Unbehaun A., Schellenberg B., Mayer B., Werner-Felmayer G., Werner E.R. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 2001, 276:40-47.
15. Baker T.A., Milstien S., Katusic Z.S. Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells. J Cardiovasc Pharmacol 2001, 37:333-338.
16. Chatterjee I.B., Majumder A.K., Nandi B.K., Subramanian N. Synthesis and some major functions of vitamin C in animals. Ann New York Acad Sci 1975, 258:24-47.
17. Tveden-Nyborg P., Hasselholt S., Miyashita N., Moos T., Poulsen H.E., Lykkesfeldt J. Chronic vitamin C deficiency does not accelerate oxidative stress in ageing brains of guinea pigs. Basic Clin Pharmacol Toxicol 2012, 110:524-529.
18. Jensen P.O., Lykkesfeldt J., Bjarnsholt T., Hougen H.P., Hoiby N., Ciofu O. Poor antioxidant status exacerbates oxidative stress and inflammatory response to Pseudomonas aeruginosa lung infection in guinea pigs. Basic Clin Pharmacol Toxicol 2012, 110:353-358.
19. Schjoldager J.G., Tveden-Nyborg P., Lykkesfeldt J. Prolonged maternal vitamin C deficiency overrides preferential fetal ascorbate transport but does not influence perinatal survival in guinea pigs. Br J Nutr 2013, 1-7.
20. Tveden-Nyborg P., Lykkesfeldt J. Does vitamin C deficiency increase lifestyle-associated vascular disease progression? evidence based on experimental and clinical studies. Antioxid Redox Signal 2013, http://dx.doi.org/10.1089/ars.2013.5382 [Epub ahead of print].
21. Tveden-Nyborg P., Johansen L.K., Raida Z., Villumsen C.K., Larsen J.O., Lykkesfeldt J. Vitamin C deficiency in early postnatal life impairs spatial memory and reduces the number of hippocampal neurons in guinea pigs. Am J Clin Nutr 2009, 90:540-546.
22. Tveden-Nyborg P., Vogt L., Schjoldager J.G., Jeannet N., Hasselholt S., Paidi M.D., et al. Maternal vitamin C deficiency during pregnancy persistently impairs hippocampal neurogenesis in offspring of guinea pigs. PLoS ONE 2012, 7:e48488.
23. Lykkesfeldt J. Determination of ascorbic acid and dehydroascorbic acid in biological samples by high-performance liquid chromatography using subtraction methods: reliable reduction with tris[2-carboxyethyl]phosphine hydrochloride. Anal Biochem 2000, 282:89-93.
24. Lykkesfeldt J. Ascorbate and dehydroascorbic acid as reliable biomarkers of oxidative stress: analytical reproducibility and long-term stability of plasma samples subjected to acidic deproteinization. Cancer Epidemiol Biomarkers Prev 2007, 16:2513-2516.
25. Lykkesfeldt J. Ascorbate and dehydroascorbic acid as biomarkers of oxidative stress: validity of clinical data depends on vacutainer system used. Nutr Res 2012, 32:66-69.
26. Lykkesfeldt J., Loft S., Poulsen H.E. Determination of ascorbic acid and dehydroascorbic acid in plasma by high-performance liquid chromatography with coulometric detection-are they reliable biomarkers of oxidative stress?. Anal Biochem 1995, 229:329-335.
27. Hyland K. Estimation of tetrahydro-, dihydro- and fully oxidized pterins by high-performance liquid chromatography using sequential electrochemical and fluorometric detection. J Chromatogr Biomed Appl 1985, 343:35-41.
28. Agarwal M., Mehta P.K., Dwyer J.H., Dwyer K.M., Shircore A.M., Nordstrom C.K., et al. Differing relations to early atherosclerosis between vitamin C from supplements vs. food in the Los angeles atherosclerosis study: a prospective cohort study. Open Cardiovasc Med J 2012, 6:113-121.
29. Myint P.K., Luben R.N., Welch A.A., Bingham S.A., Wareham N.J., Khaw K.T. Plasma vitamin C concentrations predict risk of incident stroke over 10 y in 20 649 participants of the European Prospective Investigation into Cancer Norfolk prospective population study. Am J Clin Nutr 2008, 87:64-69.
30. Langlois M., Duprez D., Delanghe J., De B.M., Clement D.L. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 2001, 103:1863-1868.
31. Simon J.A., Hudes E.S., Browner W.S. Serum ascorbic acid and cardiovascular disease prevalence in U.S. adults. Epidemiology 1998, 9:316-321.
32. Heart Protection Study Collaborative G MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360:23-33.
33. Hercberg S., Galan P., Preziosi P., Bertrais S., Mennen L., Malvy D., et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004, 164:2335-2342.
34. Cook N.R., Albert C.M., Gaziano J.M., Zaharris E., MacFadyen J., Danielson E., et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med 2007, 167:1610-1618.
35. Avenell A., Campbell M.K., Cook J.A., Hannaford P.C., Kilonzo M.M., McNeill G., et al. Effect of multivitamin and multimineral supplements on morbidity from infections in older people (MAVIS trial): pragmatic, randomised, double blind, placebo controlled trial. Brit Med J 2005, 331:324-329.
36. Frei B., Birlouez-Aragon I., Lykkesfeldt J. Authors' perspective: what is the optimum intake of vitamin C in humans?. Crit Rev Food Sci Nutr 2012, 52:815-829.
37. May J.M. How does ascorbic acid prevent endothelial dysfunction?. Free Radic Biol Med 2000, 28:1421-1429.
38. Mittermayer F., Pleiner J., Schaller G., Zorn S., Namiranian K., Kapiotis S., et al. Tetrahydrobiopterin corrects Escherichia coli endotoxin-induced endothelial dysfunction. Am J Physiol 2005, 289:H1752-H1757.
39. Nakai K., Urushihara M., Kubota Y., Kosaka H. Ascorbate enhances iNOS activity by increasing tetrahydrobiopterin in RAW 264.7 cells. Free Radic Biol Med 2003, 35:929-937.
40. Valent S., Toth M. Spectrophotometric analysis of the protective effect of ascorbate against spontaneous oxidation of tetrahydrobiopterin in aqueous solution: kinetic characteristics and potentiation by catalase of ascorbate action. Int J Biochem Cell Biol 2004, 36:1266-1280.
41. Patel K.B., Stratford M.R.L., Wardman P., Everett S.A. Oxidation of tetrahydrobiopterin by biological radicals and scavenging of the trihydrobiopterin radical by ascorbate. Free Radic Biol Med 2002, 32:203-211.
42. Gotoh N., Niki E. Rates of interactions of superoxide with vitamin E, vitamin C and related compounds as measured by chemiluminescence. Biochim Biophys Acta 1992, 1115:201-207.
43. Vásquez-Vivar J., Whitsett J., Martásek P., Hogg N., Kalyanaraman B. Reaction of tetrahydrobiopterin with superoxide: EPR-kinetic analysis and characterization of the pteridine radical. Free Radic Biol Med 2001, 31:975-985.
44. Jackson T.S., Xu A., Vita J.A., Keaney J.F. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 1998, 83:916-922.
45. May J.M., Qu Z.-C., Qiao H. Transfer of ascorbic acid across the vascular endothelium: mechanism and self-regulation. Am J Physiol 2009, 297:C169-C178.
46. Ladurner A., Schmitt C.A., Schachner D., Atanasov A.G., Werner E.R., Dirsch V.M., et al. Ascorbate stimulates endothelial nitric oxide synthase enzyme activity by rapid modulation of its phosphorylation status. Free Radic Biol Med 2012, 52:2082-2090.
47. Erwin P.A., Lin A.J., Golan D.E., Michel T. Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 2005, 280:19888-19894.
48. Izumi K., Cassens R.G., Greaser M.L. Reaction of nitrite with ascorbic acid and its significant role in nitrite-cured food. Meat Sci 1989, 26:141-153.
49. Lundberg J.O., Weitzberg E. Nitrite reduction to nitric oxide in the vasculature. Am J Physiol 2008, 295:H477-H478.
50. d'Uscio L.V., Milstien S., Richardson D., Smith L., Katusic Z.S. Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ Res 2003, 92:88-95.
51. Okazaki T, Otani H, Shimazu T, Yoshioka K, Fujita M, Iwasaka T. Ascorbic acid and N-acetyl cysteine prevent uncoupling of nitric oxide synthase and increase tolerance to ischemia/reperfusion injury in diabetic rat heart. In Free Radic Res, vol. 45. pp. 1173-83: Life Sci; 2011:1173-83.
52. Chatterjee M., Saluja R., Kumar V., Jyoti A., Kumar Jain G., Kumar Barthwal M., et al. Ascorbate sustains neutrophil NOS expression, catalysis, and oxidative burst. Free Radic Biol Med 2008, 45:1084-1093.
53. Fekkes D., Voskuilen-Kooijman A. Quantitation of total biopterin and tetrahydrobiopterin in plasma. Clin Biochem 2007, 40:411-413.
54. Fiege B., Ballhausen D., Kierat L., Leimbacher W., Goriounov D., Schircks B., et al. Plasma tetrahydrobiopterin and its pharmacokinetics following oral administration. Mol Gen Metab 2004, 81:45-51.
55. Powers A.G., Young J.H., Clayton B.E. Estimation of tetrahydrobiopterin and other pterins in plasma by isocratic liquid chromatography with electrochemical and fluorimetric detection. J Chromatogr Biomed Appl 1988, 432:321-328.
56. Blair JA, Whitburn SB, Pheasant AE, Leeming RJ, Morar C, Al-Beir A. A critical appraisal of methods for the quantitative analysis of tetrahydrobiopterin, dihydrobiopterin and biopterin in human urine, serum and CSF. Edited by Blair JA. Walter de Gruyter & Co.:165-9.
57. Fukushima T., Nixon J.C. Analysis of reduced forms of biopterin in biological tissues and fluids. Anal Biochem 1980, 102:176-188.
58. Antoniades C., Shirodaria C., Van A.T., Cunnington C., Tegeder I., Lotsch J., et al. GCH1 haplotype determines vascular and plasma biopterin availability in coronary artery disease effects on vascular superoxide production and endothelial function. J Am Coll Cardiol 2008, 52:158-165.
59. Hashimoto R., Ozaki N., Ohta T., Kasahara Y., Kaneda N., Nagatsu T. The plasma tetrahydrobiopterin levels in patients with affective disorders. Biol Psychiat 1990, 28:526-528.
60. Oppenheimer DI, Dorenbaum A, Okhamafe A, Foehr E, Castillo S, Kostel PJ. Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring. WO: (Biomarin Pharmaceutical Inc.,USA). 2008.
61. Antoniades C., Shirodaria C., Crabtree M., Rinze R., Alp N., Cunnington C., et al. Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation. Circulation 2007, 116:2851-2859.
62. Shinozaki K., Hirayama A., Nishio Y., Yoshida Y., Ohtani T., Okamura T., et al. Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress. J Am Coll Cardiol 2001, 38:1821-1828.
63. Yada T., Kaji S., Akasaka T., Mochizuki S., Ogasawara Y., Tanemoto K., et al. Changes of asymmetric dimethylarginine, nitric oxide, tetrahydrobiopterin, and oxidative stress in patients with acute myocardial infarction by medical treatments. Clin Hemorheol Micro 2007, 37:269-276.
64. Cosentino F., Hürlimann D., Delli Gatti C., Chenevard R., Blau N., Alp N.J., et al. Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart 2008, 94:487-492.
65. Andondonskaja-Renz B., Zeitler H.-J. Separation of pteridines from blood cells and plasma by reverse-phase high-performance liquid chromatography. Anal Biochem 1983, 133:68-78.
66. Zhao Y., Cao J., Chen Y.-S., Zhu Y., Patrick C., Chien B., et al. Detection of tetrahydrobiopterin by LC-MS/MS in plasma from multiple species. Bioanalysis 2009, 1:895-903.
67. Richardson M.A., Read L.L., Taylor Clelland C.L., Reilly M.A., Chao H.M., Guynn R.W., et al. Evidence for a tetrahydrobiopterin deficit in schizophrenia. Neuropsychobiology 2005, 52:190-201.
68. Omura I., Mizutani M., Goto S., Hashimoto R., Kitagami T., Miura H., et al. Plasma biopterin levels and depressive state in pregnancy and the early puerperal period. Neuropsychobiology 2002, 45:134-138.
69. Slazyk W.E., Spierto F.W. Liquid-chromatographic measurement of biopterin and neopterin in serum and urine. Clin Chem 1990, 36:1364-1368.
70. Mochizuki S., Ono J., Yada T., Ogasawara Y., Miyasaka T., Kimoto M., et al. Systemic nitric oxide production rate during hemodialysis and its relationship with nitric oxide-related factors. Blood Purif 2005, 23:317-324.
71. He L., Zeng H., Li F., Feng J., Liu S., Liu J., et al. Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia. Am J Physiol 2010, 299:E1061-E1065.
72. Mayahi L., Mason L., Bleasdale-Barr K., Donald A., Trender-Gerhard I., Sweeney M.G., et al. Endothelial, sympathetic, and cardiac function in inherited (6R)-l-erythro-5,6,7,8-tetrahydro-l-biopterin deficiency. Circulation 2010, 3:513-522.
73. Antoniades C., Bakogiannis C., Leeson P., Guzik T.J., Zhang M.H., Tousoulis D., et al. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling/clinical perspective. Circulation 2011, 124:335-345.
74. Mizutani M., Hashimoto R., Ohta T., Nakazawa K., Nagatsu T. The effect of exercise on plasma biopterin levels. Neuropsychobiology 1994, 29:53-56.
75. Hashimoto R., Mizutani M., Ohta T., Nakazawa K., Nagatsu T. Changes in plasma tetrahydrobiopterin levels of depressives in depressive and remission phases-reconfirmed by measurement with an internal standard. Neuropsychobiology 1994, 29:57-60.
76. Hashimoto R., Ozaki N., Ohta T., Kasahara Y., Kaneda N., Nagatsu T. Plasma tetrahydrobiopterin levels in patients with psychiatric-disorders. Neuropsychobiology 1990, 23:140-143.
77. Hashimoto R., Ozaki N., Ohta T., Kasahara Y., Kaneda N., Nagatsu T. Plasma biopterin levels of patients with affective-disorders. Neuropsychobiology 1988, 19:61-63.
78. Hashimoto R., Ozaki N., Ohta T., Kasahara Y., Kaneda N., Nagatsu T. Total biopterin levels of plasma in patients with depression. Neuropsychobiology 1987, 17:176-177.
79. Hoekstra R., van den Broek W.W., Fekkes D., Bruijn J.A., Mulder P.G.H., Pepplinkhuizen L. Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe, medication-resistant depression. Psychiat Res 2001, 103:115-123.
80. Yokoyama K., Tajima M., Yoshida H., Nakayama M., Tokutome G., Sakagami H., et al. Plasma pteridine concentrations in patients with chronic renal failure. Nephrol Dial Transpl 2002, 17:1032-1036.
81. 4) levels and coronary artery disease. Cardiology 2000, 94:265-266.
82. Cunnington C., Van Assche T., Shirodaria C., Kylintireas I., Lindsay A.C., Lee J.M., et al. Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease. Circulation 2012, 125:1356-1366.
83. Hoshiai K., Hattan N., Fukuyama N., Tadaki F., Hida M., Saito A., et al. Increased plasma tetrahydrobiopterin in septic shock is a possible therapeutic target. Pathophysiology 2001, 7:275-281.
84. Mortensen A., Lykkesfeldt J. Kinetics of acid-induced degradation of tetra- and dihydrobiopterin in relation to their relevance as biomarkers of endothelial function. Biomarkers 2013, 18:55-62.
85. Sawabe K., Saeki Y., Ohashi A., Mamada K., Wakasugi K.O., Matsuoka H., et al. Tetrahydrobiopterin in intestinal lumen: its absorption and secretion in the small intestine and the elimination in the large intestine. J Inherit Metab Dis 2009, 32:79-85.
86. Kim H.L., Kim D.H., Lee Y.K., Park S.O., Lee Y.W., Kwon O.S., et al. An enzymatic method to distinguish tetrahydrobiopterin from oxidized biopterins using UDP-glucose:tetrahydrobiopterin glucosyltransferase. Anal Biochem 2010, 397:79-83.
87. Schmidt T.S., McNeill E., Douglas G., Crabtree M.J., Hale A.B., Khoo J., et al. Tetrahydrobiopterin supplementation reduces atherosclerosis and vascular inflammation in apolipoprotein E-knockout mice. Clin Sci 2010, 119:131-142.
88. Haruna Y., Morita Y., Komai N., Yada T., Sakuta T., Tomita N., et al. Endothelial dysfunction in rat adjuvant-induced arthritis: vascular superoxide production by NAD(P)H oxidase and uncoupled endothelial nitric oxide synthase. Arthrit Rheumat 2006, 54:1847-1855.
89. Noguchi K., Hamadate N., Matsuzaki T., Sakanashi M., Nakasone J., Sakanashi M., et al. Improvement of impaired endothelial function by tetrahydrobiopterin in stroke-prone spontaneously hypertensive rats. Eur J Pharmacol 2010, 631:28-35.
90. Hoshiga M., Hatakeyama K., Watanabe M., Shimada M., Kagamiyama H. Autoradiographic distribution of [14C]tetrahydrobiopterin and its developmental change in mice. J Pharmacol Exp Therap 1993, 267:971-978.
91. Ohashi A., Suetake Y., Saeki Y., Harada T., Aizawa S., Hasegawa H. Rapid clearance of supplemented tetrahydrobiopterin is driven by high-capacity transporters in the kidney. Mol Gen Metab 2012, 105:575-581.
92. Goldberg M., Fuchs C. Studies and comparison of pterin patterns in the plasma of dogs and cats and their alteration in various neoplasias and virus infections. J Vet Med 1996, 43:201-209.